Infection, Relapses, and Pseudo-Relapses in Individuals With Multiple Sclerosis.

Publication date: Aug 01, 2025

Infections are associated with an increased risk of relapse and pseudo-relapse in persons with multiple sclerosis (MS). However, the relationship with relapses and pseudo-relapses after SARS-CoV-2 infections (COVID) vs other infections in MS is poorly understood. Therefore, we compared the occurrence of relapse and pseudo-relapse after COVID and other infections with noninfected participants with MS. In spring 2023, we surveyed participants from the North American Research Committee on Multiple Sclerosis Registry regarding whether they had had a COVID infection, other infections, relapses, and pseudo-relapses. Recent infections, occurring in the 6 months before the survey, were used to categorize participants into groups: recent COVID, non-COVID infection (with no history of ever having COVID), COVID and non-COVID infections, or uninfected. Of the 4,787 participants eligible for analysis, 2,927 participants were included, of whom 294 (10%) had a recent COVID infection; 853 (29. 1%) had 1 recent infection other than COVID; 246 (8. 4%) had a recent COVID and non-COVID infection; and 1,534 (52. 4%) had no infection with COVID nor any infection within the past 6 months (uninfected). Compared with no infections, non-COVID infection was associated with a 39% increased likelihood of relapse (1. 39, 95% CI [1. 04-1. 87]), whereas a recent COVID infection was associated with a decreased likelihood of relapse (0. 45 [0. 23, 0. 87]), adjusting for covariates. All infection groups were associated with increased odds of pseudo-relapse compared with the uninfected group (non-COVID infections: 1. 78 [1. 44, 2. 20]; COVID infection: 1. 80 [1. 32, 2. 45]; COVID and non-COVID infection: 3. 04 [2. 24, 4. 12]). Because individuals with MS are at increased risk of infections, the association of infections with relapses and pseudo-relapses is clinically important. The high prevalence of acute worsening after infection, regardless of the type of infection, compared with those with no reported infection, needs to be considered in the management of persons with MS.

Concepts Keywords
American Compared
Covid Covid
Sclerosis Increased
Infection
Infections
Ms
Multiple
Non
Participants
Pseudo
Recent
Relapse
Relapses
Sclerosis
Uninfected

Semantics

Type Source Name
disease MESH Infection
disease MESH Relapses
disease MESH Multiple Sclerosis
disease MESH SARS-CoV-2 infections
disease IDO history
disease MESH Long Covid

Original Article

(Visited 1 times, 1 visits today)